Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GoPro Inc (GPRO) vs Hims and Hers Health Inc (HIMS) Price & Performance

Hims and Hers Health IncTrade

Price performance (Past 24H)

Key statistics

GoPro Inc vs Hims and Hers Health Inc — how do they compare? GoPro Inc trades at $0.62 (market cap $120.42M), while Hims and Hers Health Inc trades at $30.77 (market cap $7.35B). The key difference: Hims and Hers Health Inc is far larger — about 61× GoPro Inc's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.

GPROHIMS
Market Cap
$120.42M$7.35B
Sector
TechnologyHealth
52-Week High
$2.88$62.76
52-Week Low
$0.62$14.52
Enterprise Value
$168.37M$7.73B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GoPro Inc

GoPro (GPRO) trades at $0.73, down 0.38% on the day, reflecting persistent financial distress. The stock is in a bearish technical trend, with negative earnings surprises in recent quarters and a net income margin of -20.7% for 2025. Revenue has declined from $1.1B in 2022 to $652M in 2025, while the company is actively pursuing strategic alternatives, including a potential sale, as announced in May 2026.

The outlook is highly speculative, hinging on the outcome of the strategic review. A successful sale could unlock value, but fundamental weaknesses—including cash burn, negative equity, and competitive pressures—pose significant risks. Analyst sentiment is mixed, with a majority Hold rating, indicating caution amid the binary event-driven thesis.

Hims and Hers Health Inc

Hims & Hers Health stock trades at $31.59, up 6.51% today, showing strong momentum. The technical outlook is bullish, with the price above key moving averages and support at $30. Fundamentally, revenue growth is robust at 40% year-over-year in Q2 2026 (MarketBeat, 2026-08-10), but profitability remains challenged with a net loss margin of -0.56% in 2026. The company raised its annual revenue forecast to $3.1–3.3 billion (WSJ, 2026-08-10), reflecting confidence in subscriber growth and expansion into weight-loss treatments.

The investment outlook is mixed: strong revenue growth and bullish analyst targets near $35.60 offer upside, but high valuation ratios (P/E of 57.14) and recent earnings misses heighten risk. Key risks include margin pressure from GLP-1 investments and ongoing legal investigations. Wall Street sentiment is cautious, with 65% hold ratings, suggesting patience for profitability improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GoPro Inc

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.

Read more on GPRO

About Hims and Hers Health Inc

Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.

Read more on HIMS